SMMT - Summit Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 534.84M
Enterprise Value 34.72M
Trailing P/E N/A
Forward P/E 1-1.61
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.80
Price/Book (mrq)2.16
Enterprise Value/Revenue 30.11
Enterprise Value/EBITDA 6-0.26

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2018
Most Recent Quarter (mrq)Apr 30, 2018

Profitability

Profit Margin -24.99%
Operating Margin (ttm)-43.21%

Management Effectiveness

Return on Assets (ttm)-18.74%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)43.4M
Revenue Per Share (ttm)3.14
Quarterly Revenue Growth (yoy)323.90%
Gross Profit (ttm)27.24M
EBITDA -18.19M
Net Income Avi to Common (ttm)-10.85M
Diluted EPS (ttm)-0.770
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.6M
Total Cash Per Share (mrq)2.23
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.83
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)-18.21M
Levered Free Cash Flow (ttm)-4.07M

Trading Information

Stock Price History

Beta 0.94
52-Week Change 3-82.28%
S&P500 52-Week Change 316.87%
52 Week High 316.861
52 Week Low 31.940
50-Day Moving Average 32.405
200-Day Moving Average 310.355

Share Statistics

Avg Vol (3 month) 3154.26k
Avg Vol (10 day) 380.21k
Shares Outstanding 561.93M
Float 11.07M
% Held by Insiders 11.42%
% Held by Institutions 125.35%
Shares Short (Jun 15, 2018) 4228.98k
Short Ratio (Jun 15, 2018) 48.51
Short % of Float (Jun 15, 2018) 4N/A
Short % of Shares Outstanding (Jun 15, 2018) 41.40%
Shares Short (prior month May 15, 2018) 4298.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A